- Home
- STC vs SUPN Comparison
STC vs SUPN Comparison
Compare STC & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STC
- SUPN
- Stock Information
- Founded
- STC 1893
- SUPN 2005
- Country
- STC United States
- SUPN United States
- Employees
- STC N/A
- SUPN N/A
- Industry
- STC Specialty Insurers
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- STC Finance
- SUPN Health Care
- Exchange
- STC Nasdaq
- SUPN Nasdaq
- Market Cap
- STC 2.0B
- SUPN 1.9B
- IPO Year
- STC N/A
- SUPN 2012
- Fundamental
- Price
- STC $62.86
- SUPN $32.28
- Analyst Decision
- STC Buy
- SUPN Hold
- Analyst Count
- STC 3
- SUPN 2
- Target Price
- STC $77.67
- SUPN $36.00
- AVG Volume (30 Days)
- STC 205.6K
- SUPN 529.3K
- Earning Date
- STC 07-23-2025
- SUPN 08-05-2025
- Dividend Yield
- STC 3.18%
- SUPN N/A
- EPS Growth
- STC 72.76
- SUPN N/A
- EPS
- STC 2.60
- SUPN 1.11
- Revenue
- STC $2,547,588,000.00
- SUPN $667,997,000.00
- Revenue This Year
- STC $11.17
- SUPN N/A
- Revenue Next Year
- STC $11.31
- SUPN $12.02
- P/E Ratio
- STC $24.16
- SUPN $29.32
- Revenue Growth
- STC 11.27
- SUPN 11.82
- 52 Week Low
- STC $58.61
- SUPN $25.55
- 52 Week High
- STC $78.44
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- STC 51.41
- SUPN 48.28
- Support Level
- STC $60.08
- SUPN $31.56
- Resistance Level
- STC $64.35
- SUPN $33.15
- Average True Range (ATR)
- STC 1.55
- SUPN 0.92
- MACD
- STC 0.28
- SUPN -0.03
- Stochastic Oscillator
- STC 73.91
- SUPN 40.34
About STC Stewart Information Services Corporation
Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.